Evidence map›Paper›PMID 27102646›Full record

ArticleScientific reports2016

Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process.

E Scalici, S Traver, T Mullet, N Molinari, A Ferrières, C Brunet, S Belloc, S Hamamah

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 5 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 5 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Review
  9. Beyond Repetition: The Role of Gray Zone Alleles in the Upregulation ofInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. The Beneficial Effects ofInternational journal of molecular sciences · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

E ScaliciCHU Montpellier, Institute of Regenerative Medicine and Biotherapy, Saint-Eloi Hospital, INSERM U1203, Montpellier, France.
S TraverCHU Montpellier, Institute of Regenerative Medicine and Biotherapy, Saint-Eloi Hospital, INSERM U1203, Montpellier, France.
T MulletCHU Montpellier, Institute of Regenerative Medicine and Biotherapy, Saint-Eloi Hospital, INSERM U1203, Montpellier, France.
N MolinariUMR 1049, DIM, CHRU, Montpellier, France.
A FerrièresART-PGD Department, Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France.
C BrunetART-PGD Department, Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France.
S BellocEylau/Unilabs Laboratory, Reproductive Biology Unit, 55 Rue Saint Didier, 75016 Paris, France.
S HamamahCHU Montpellier, Institute of Regenerative Medicine and Biotherapy, Saint-Eloi Hospital, INSERM U1203, Montpellier, France.
Hôpital Arnaud de Villeneuve · FRInstitute for Regenerative Medicine & Biotherapy · FRInserm · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating or "extracellular" microRNAs (miRNAs) detected in biological fluids, could be used as potential diagnostic and prognostic biomarkers of several disease, such as cancer, gynecological and pregnancy disorders. However, their contributions in female infertility and in vitro fertilization (IVF) remain unknown. This study investigated the expression profiles of five circulating miRNAs (let-7b, miR-29a, miR-30a, miR-140 and miR-320a) in human follicular fluid from 91 women with normal ovarian reserve and 30 with polycystic ovary syndrome (PCOS) and their ability to predict IVF outcomes. The combination of FF miR-30a, miR-140 and let-7b expression levels discriminated between PCOS and normal ovarian reserve with a specificity of 83.8% and a sensitivity of 70% (area under the ROC curve, AUC = 0.83 [0.73-0.92]; p < 0.0001). FF samples related to low number of mature oocytes (≤2) contained significant less miR-320a levels than those related to a number of mature oocytes >2 (p = 0.04). Moreover, FF let-7b predicted the development of expanded blastocysts with 70% sensitivity and 64.3% specificity (AUC = 0.67 [0.54-0.79]; p = 0.02) and FF miR-29a potential to predict clinical pregnancy outcome reached 0.68 [0.55-0.79] with a sensitivity of 83.3% and a specificity of 53.5% (p = 0.01). Therefore, these miRNAs could provide new helpful biomarkers to facilitate personalized medical care during IVF.

Indexed as

Fertilization in VitroAdultCirculating MicroRNADiagnostic Tests, RoutineFemaleFollicular FluidHumansPolycystic Ovary SyndromePrecision MedicineSensitivity and SpecificityYoung AdultCirculating MicroRNA

Identifiers

PMID27102646
PMCPMC4840336
OpenAlexW2339162314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.